Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 22, 2026
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms.
Journal: ACS pharmacology & translational science
Published: November 15, 2020
PAX8 and MECOM are interaction partners driving ovarian cancer.
Journal: Nature communications
Published: July 27, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026